Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Ann Surg Oncol. 2012 Oct;19(11):3598-605. doi: 10.1245/s10434-012-2414-3. Epub 2012 May 30.
We investigated the association between the newly proposed International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification and (18)F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET), and whether the combination of these radiologic and pathologic factors can further prognostically stratify patients with stage I lung adenocarcinoma.
We retrospectively evaluated 222 patients with pathologic stage I lung adenocarcinoma who underwent FDG-PET scanning before undergoing surgical resection between 1999 and 2005. Patients were classified by histologic grade according to the IASLC/ATS/ERS classification (low, intermediate, or high grade) and by maximum standard uptake value (SUVmax) (low <3.0, high ≥3.0). The cumulative incidence of recurrence (CIR) was used to estimate recurrence probabilities.
Patients with high-grade histology had higher risk of recurrence (5-year CIR, 29% [n = 25]) than those with intermediate-grade (13% [n = 181]) or low-grade (11% [n = 16]) histology (p = 0.046). High SUVmax was associated with high-grade histology (p < 0.001) and with increased risk of recurrence compared to low SUVmax (5-year CIR, 21% [n = 113] vs. 8% [n = 109]; p = 0.013). Among patients with intermediate-grade histology, those with high SUVmax had higher risk of recurrence than those with low SUVmax (5-year CIR, 19% [n = 87] vs. 7% [n = 94]; p = 0.033). SUVmax was associated with recurrence even after adjusting for pathologic stage (p = 0.037).
SUVmax on FDG-PET correlates with the IASLC/ATS/ERS classification and can be used to stratify patients with intermediate-grade histology, the predominant histologic subtype, into two prognostic subsets.
我们研究了新提出的国际肺癌研究协会(IASLC)/美国胸科学会(ATS)/欧洲呼吸学会(ERS)分类与正电子发射断层扫描(PET)上的(18)F-氟脱氧葡萄糖(FDG)摄取之间的关系,以及这些影像学和病理学因素的组合是否可以进一步对 I 期肺腺癌患者进行预后分层。
我们回顾性评估了 2005 年前在接受手术切除前于 1999 年至 2005 年间接受 FDG-PET 扫描的 222 例 I 期肺腺癌患者。患者根据 IASLC/ATS/ERS 分类(低、中、高级)和最大标准摄取值(SUVmax)(低 <3.0,高≥3.0)进行组织学分级分类。累积复发率(CIR)用于估计复发概率。
高级别组织学患者的复发风险更高(5 年 CIR,29%[n=25]),高于中级别(13%[n=181])或低级别(11%[n=16])组织学患者(p=0.046)。高 SUVmax 与高级别组织学相关(p<0.001),与低 SUVmax 相比,复发风险增加(5 年 CIR,21%[n=113] vs. 8%[n=109];p=0.013)。在中级别组织学患者中,高 SUVmax 患者的复发风险高于低 SUVmax 患者(5 年 CIR,19%[n=87] vs. 7%[n=94];p=0.033)。即使在调整病理分期后,SUVmax 与复发仍相关(p=0.037)。
FDG-PET 上的 SUVmax 与 IASLC/ATS/ERS 分类相关,可用于将中级别组织学(主要组织学亚型)患者分层为两个预后亚组。